KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression

被引：51
|
作者：
Ali, A. [1 ,2 ]
Zhang, P. [3 ]
Liangfang, Y. [2 ]
Wenshe, S. [2 ]
Wang, H. [2 ]
Lin, X. [4 ]
Dai, Y. [1 ]
Feng, X-H [4 ]
Moses, R. [4 ]
Wang, D. [1 ]
Li, X. [4 ]
Xiao, J. [5 ]
机构：
[1] Yangzhou Univ, Coll Med, Nortern Jiangsu Peoples Hosp, Yangzhou 225001, Jiangsu, Peoples R China
[2] E China Normal Univ, Shanghai Key Lab Brain Funct Genom,Sch Life Sci, Key Lab Brain Funct Genom,Inst Biomed Sci, Shanghai Key Lab Regulatory Biol,Minist Educ, Shanghai 200241, Peoples R China
[3] Second Chengdu Municipal Hosp, Dept Pathol, Chengdu 610017, Sichuan, Peoples R China
[4] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[5] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, Shanghai 200003, Peoples R China
来源：
CELL DEATH & DISEASE | 2015年 / 6卷
基金：
中国国家自然科学基金;
关键词：
FACTOR-BETA; TRANSCRIPTION FACTORS; C-MYC; SMAD3; FAMILY; P53; MECHANISMS; EXPRESSION; REPRESSION; PROGNOSIS;
D O I：
10.1038/cddis.2015.48
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Inhibition of tumor suppressive signaling is linked to cancer progression, metastasis and epithelial-mesenchymal transition (EMT). Transforming growth factor-beta 1 (TGF-beta)/Smad signaling plays an important role in tumor suppression. Kruppel-like-factor 17 (KLF17) is a negative regulator of metastasis and EMT. However, underlying mechanisms leading to tumor suppressive and anti-metastatic function of KLF17 still remains unknown. Here, we show that KLF17 plays an integral role in potentiating TGF-beta/Smad signaling via Smad3-dependent pathway to suppress tumor progression. Intriguingly, TGF-beta/Smad3 signaling induces KLF17 expression, generating a positive feedback loop. TGF-beta/Smad3-KLF17 loop is critical for anti-metastasis and tumor inhibition in cancer cells. Mechanistically, silencing KLF17 reduced Smad3-DNA complex formation on Smad binding element (SBE) and affects the expression of TGF-beta/Smad target genes. Moreover, KLF17 alters Smad3 binding pattern on chromatin. KLF17 regulates TGF-beta target genes that are Smad3-dependent. Smad3 and KLF17 physically interact with each other via KLF17 responsive elements/SBE region. Intriguingly, TGF-beta stimulates the recruitment of KLF17 on chromatin to subsets of metastasis-associated genes. Functionally, depletion of KLF17 enhanced tumorigenic features in cancer cells. KLF17 is critical for full cytostatic function of TGF-beta/Smad signaling. Clinically, KLF17 expression significantly decreases during advance HCC. KLF17 shows positive correlation with Smad3 levels in cancer samples. Our data shows that enhance KLF17 activity has important therapeutic implications for targeted-therapies aimed at TGF-beta/Smad3 pathway. These findings define novel mechanism by which TGF-beta/Smad-KLF17 pathway mutually affect each other during cancer metastasis, provide a new model of regulation of TGF-beta/Smad signaling by KLF17 and defines new insights into anti-metastatic function of KLF17.
引用
收藏
页码：e1681 / e1681
页数：13
相关论文
共 50 条
  • [1] KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression
    A Ali
    P Zhang
    Y Liangfang
    S Wenshe
    H Wang
    X Lin
    Y Dai
    X-h Feng
    R Moses
    D Wang
    X Li
    J Xiao
    Cell Death & Disease, 2015, 6 : e1681 - e1681
  • [2] TGF-β promotes cancer via Smad3-dependent microenvironments
    Lan, Hui-Yao
    Zhou, Shuang
    Meng, Xiao-Ming
    Lian, Guan-Yu
    Huang, Xiao-Ru
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S6 - S6
  • [3] SMAD7: a timer of tumor progression targeting TGF-β signaling
    Luo, Lingyu
    Li, Nianshuang
    Lv, Nonghua
    Huang, Deqiang
    TUMOR BIOLOGY, 2014, 35 (09) : 8379 - 8385
  • [4] TLP, a novel modulator of TGF-β signaling, has opposite effects on Smad2- and Smad3-dependent signaling
    Felici, A
    Wurthner, JU
    Parks, WT
    Giam, LR
    Reiss, M
    Karpova, TS
    McNally, JG
    Roberts, AB
    EMBO JOURNAL, 2003, 22 (17): : 4465 - 4477
  • [5] TGF-β/SMAD/GLI2 Signaling Axis in Cancer Progression and Metastasis
    Javelaud, Delphine
    Alexaki, Vasileia I.
    Dennler, Sylviane
    Mohammad, Khalid S.
    Guise, Theresa A.
    Mauviel, Alain
    CANCER RESEARCH, 2011, 71 (17) : 5606 - 5610
  • [6] Amplification of sonic hedgehog signaling by TGF-β:: Smad3-dependent activation of Gli transcription factors
    Dennler, S.
    André, J.
    Alexaki, I
    Javelaud, D.
    Li, A.
    Wang, X. J.
    Verrecchia, F.
    Mauviel, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 90 - 90
  • [7] Myofibroblast transdifferentiation in obliterative bronchiolitis:: TGF-β signaling through Smad3-dependent and -independent pathways
    Ramirez, A. M.
    Shen, Z.
    Ritzenthaler, J. D.
    Roman, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (09) : 2080 - 2088
  • [8] Wedelolactone suppresses breast cancer growth and metastasis via regulating TGF-β1/Smad signaling pathway
    Li, Hui
    Hou, Manting
    Zhang, Ping
    Ren, Lutong
    Guo, Yuanyuan
    Zou, Liang
    Cao, Junling
    Bai, Zhaofang
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2024, 76 (08) : 1038 - 1050
  • [9] Smad3-Dependent Signaling Underlies the TGF-β1-Mediated Enhancement in Astrocytic iNOS Expression
    Hamby, Mary E.
    Hewett, James A.
    Hewett, Sandra J.
    GLIA, 2010, 58 (11) : 1282 - 1291
  • [10] Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest
    Francisco J Nicolás
    Caroline S Hill
    Oncogene, 2003, 22 : 3698 - 3711
12345